Extended Data Fig. 1: Study overview.
From: High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Patient enrollment, inclusion and evaluable group are defined in the blue boxes. Detailed clinical, tissue and cfDNA exclusions are shown in the gray boxes.
